Source: El Blog

Despite some questioning of the benefits of hydroxychloroquine in patients with coronavirus, by some studies, the drug will continue to be used in that country, said the executive president of the Costa Rican Social Security Fund (CCSS), Román Macaya.

The official defended the use that occurs in the country of the drug, which is applied under special conditions, which generates greater safety in its use.

“In the context of COVID-19 patients, the case is first analyzed to see if that person does not have other diseases that are contraindicated for the use of hydroxychloroquine. In cases where they do not exist, they are offered to the patient and followed up daily by family doctors. 

We are giving this (hydroxychloroquine) in an outpatient setting, in a newly diagnosed patient, quite healthy, sometimes asymptomatic, “said Macaya.

Likewise, the president of the CCSS assured that the studies carried out so far are carried out in a different context from that of the country, so he rules out that it may affect local patients receiving the treatment.

“The (other) studies that have been published worldwide practically all are with hospitalized patients. Those patients were already complicated, and even more so if they entered an intensive care unit. When they are already at that level of complication, the clinical approach is usually not to fight the virus, but rather the consequences that it has already triggered. ”

Román Macaya

Macaya used the hospitalization figures in the country for COVID-19 cases to reinforce the possibility that hydroxychloroquine is effective.

In addition, he assured that “another situation is that, if we see the numbers that are occurring in Costa Rica and compare them internationally, our numbers are lower. We cannot say that it is because of the use of this medicine, but we cannot rule it out either. ”

“There are reasons to continue studying this drug, especially in an early context, newly diagnosed, and following all the guidelines of not prescribing it to people with contraindications,” he added.


Related: Hydroxychloroquine: The Drug Costa Rica Uses Successfully To Fight Covid-19

Related: Costa Rica using hydroxychloroquine for COVID-19 treatment

Share on facebook
Share on twitter
Share on whatsapp
On Trend

Latest Stories

Trouble in Paradise Surrounding the use of Ivermectin

In nations around the world tension mounts between physicians and caregivers seeking to prescribe what they professionally deem as safe doses of ivermectin, as an off-label treatment for COVID-19 and national health authorities, which for the most part have all taken a hostile and oppositional position against the use of the drug.

Read More »

How Ivermectin became a Target for the ‘Fraud Detectives.’

And why is ivermectin being so negatively targeted by Big Tech and Big Media? One could argue conflict of interest plays a major role, given how intertwined they are with Big Pharma and the far-reaching grasp of the BMGF. A cheap and effective early treatment for Covid-19, like ivermectin, can be seen as a significant threat to the financial interests of those involved with Covid vaccines and expensive anti-viral drugs.

Read More »

Canada: Alberta Failing on COVID-19 Vaccines and Treatment

Numerous studies and clinical observation of thousands of patients has indicated that Ivermectin is highly effective in this regard. Even low dose studies that were designed to reach the conclusion that ivermectin was not effective found a signal that indicated that Ivermectin effectively interacted with the COVID virus molecule to prevent or lessen replication of the virus.”

Read More »